GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound) are FDA-approved for type 2 diabetes and obesity management
Why It Matters Additional randomized, controlled trials that follow people over time are needed to confirm these findings, but these results are promising, since people with diabetes are at increased risk for developing epilepsy later in life, said study author Edy Kornelius, MD, PhD, of Chung Shan Medical University in Taichung, Taiwan
Diabetes Care 26 , 881885 (2003)
Similar content being viewed by others Subjects Introduction Hyperuricemia is a metabolic disorder marked by elevated serum uric acid concentrations in both extracellular fluids and tissues, coupled with impaired uric acid excretion
Choline intake in a large cohort of patients with nonalcoholic fatty liver disease
Medical Supervision: Administered in a clinical setting, ensuring proper dosing and monitoring